A discounted cash flow analysis suggests Westinghouse Air Brake Technologies (Wabtec) shares may be trading at a premium. We break down the valuation model, its assumptions, and the broader market forces at play for the rail equipment leader.
A wave of insider selling at The Progressive Corporation, totaling over $16 million in the past year, has prompted investors to scrutinize the insurer's outlook. While such sales aren't uncommon, the scale and timing invite questions about internal confidence as the stock trades significantly below recent insider sale prices.
The London-listed publisher, known for the Harry Potter series, is showing notable improvement in its returns on capital employed, outpacing industry averages and signaling robust reinvestment potential for future growth.
In a strategic move to diversify its portfolio and strengthen its European footprint, UK-based The Tofoo Co., backed by private equity, has acquired German seitan specialist Topas, owner of the Wheaty brand.
The payments giants Visa and Mastercard reported robust revenue and earnings growth for their latest quarters, though their premium valuations continue to spark investor debate on which offers the superior long-term opportunity.
The global payments giant reported a 15% surge in net revenue and processed a record 69.4 billion transactions in its fiscal first quarter, signaling resilient consumer confidence and a rebound from previous quarters.
Tyson Foods Inc. surpassed quarterly profit expectations, driven by resilient consumer demand for chicken. This strength helped offset significant challenges in its beef division, where historic herd shortages and soaring costs have reshaped the meat industry's landscape.
A British Columbia court has given its final approval to Coeur Mining's planned acquisition of New Gold, moving the deal that will create a North American precious metals giant one step closer to its expected H1 2026 closing.
A Dominus and Cheyne Capital partnership wins City of London approval to convert the Grade II-listed Ibex House into a 382-room hotel, slated for a late 2028 opening, complete with a hospitality academy and restored pub.
Amazon's recent workforce reductions, bringing total corporate cuts to 30,000, reflect a broader shift in how layoffs are perceived. No longer framed as a sign of failure, they are increasingly presented as a strategic, forward-looking move to streamline operations and focus on priorities like AI, a narrative that resonates with investors despite the human impact.
Amgen has transferred full rights for the atopic dermatitis drug rocatinlimab back to Kyowa Kirin, clearing the path for the Japanese firm to pursue US approval by 2026. The move comes despite the drug meeting all trial endpoints, reflecting Amgen's portfolio reprioritization and a tempered market outlook for the OX40 inhibitor class.
A new discounted cash flow analysis suggests shares of the German industrial giant KION GROUP AG could be undervalued by nearly 30%, presenting a potential opportunity for investors amid broader market volatility.
A stark consensus is emerging among prediction market traders and analysts, with a 71% probability now priced in for Bitcoin to fall below $65,000 within two years. This bearish outlook follows a weekend sell-off to nine-month lows and is supported by underwater ETF positions, technical warnings, and concerns over a sustained market downturn rather than a temporary correction.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
Analysts at Piper Sandler have increased their price target for Permian Basin-focused producer Diamondback Energy (FANG) to $218, maintaining an Overweight rating. The move comes as the firm anticipates solid Q4 results for gas-focused companies, while oil producers navigate a tougher pricing environment.
Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
Insurance brokerage giant Brown & Brown sees a key price target cut to $81 following its fourth-quarter earnings, which revealed robust fee growth but concerns over slowing organic revenue expansion.
Analyst Joe Laetsch raises HF Sinclair's price target, highlighting favorable crude differentials and a recent $38 million acquisition aimed at expanding its lubricants business, as the refiner lands on a list of top low-risk dividend stocks.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
